Anlon Healthcare Stock Screener | Share Price & Fundamental Analysis
AHCL
Pharmaceuticals
Screen Anlon Healthcare share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹142.42
▼
-1.88 (-1.30%)
Share Price BSE
₹143.35
▼
-0.30 (-0.21%)
Market Cap
₹756.98 Cr.
P/E Ratio (TTM)
37.22
P/B Ratio
3.79
EPS (TTM)
₹6.37
Dividend Yield
-
Debt to Equity
1.46
52W High
₹154.70
52W Low
₹106.64
Operating Margin
24.00%
Profit Margin
13.51%
Revenue (TTM)
₹148.00
EBITDA
₹35.00
Net Income
₹20.00
Total Assets
₹181.00
Total Equity
₹80.00
Anlon Healthcare Share Price History - Stock Screener Chart
Screen AHCL historical share price movements with interactive charts. Analyze price trends and patterns.
Anlon Healthcare Company Profile - Fundamental Screener
Screen Anlon Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AHCL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0Y8W01017
Anlon Healthcare Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen AHCL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 181 | 128 | 112 | 85 | 71 |
| Current Assets | 159 | 101 | 86 | 58 | 40 |
| Fixed Assets | 23 | 27 | 26 | 27 | 29 |
| Liabilities | |||||
| Total Liabilities | 181 | 128 | 112 | 85 | 71 |
| Current Liabilities | 41 | 57 | 61 | 55 | 38 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 80 | 21 | 7 | 2 | 2 |
| Share Capital | 40 | 16 | 12 | 12 | 12 |
| Reserves & Surplus | 41 | 5 | -5 | -10 | -10 |
Screen AHCL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
| Revenue | 148 | 121 | 67 | 113 | 58 | 16 |
| Expenses | 113 | 88 | 51 | 101 | 52 | 21 |
| EBITDA | 35 | 32 | 16 | 13 | 6 | -5 |
| Operating Profit % | 24.00% | 27.00% | 23.00% | 11.00% | 9.00% | -33.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 4 | 4 | 4 | 4 | 4 | 3 |
| Profit Before Tax | 29 | 27 | 10 | 7 | 0 | -10 |
| Tax | 9 | 6 | 0 | 1 | 0 | 0 |
| Net Profit | 20 | 21 | 10 | 6 | 0 | -10 |
| EPS | 6.40 | 6.37 | 6.68 | 4.85 | -0.09 | -8.53 |
Anlon Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen AHCL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -23 | -3 | -3 | -2 | -15 |
| Investing Activities | 3 | -3 | 0 | 0 | -3 |
| Financing Activities | 19 | 8 | 2 | 3 | 16 |
| Net Cash Flow | -1 | 2 | -1 | 1 | -2 |
Screen AHCL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Apr | 2025-Jun | 2025-Aug | 2025-Sept | 2025-Dec | 2024-Oct |
|---|---|---|---|---|---|---|
| Promoter Holding | 70.26% | 52.68% | 70.26% | 52.68% | 52.68% | 70.26% |
| FII Holding | 0.00% | 14.42% | 0.00% | 0.00% | 0.23% | 0.00% |
| DII Holding | 0.00% | 4.35% | 0.00% | 2.83% | 4.49% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 0.00% | 14.64% | 0.00% | 20.73% | 23.58% | 0.00% |
| Other Holding | 29.74% | 13.92% | 29.74% | 23.75% | 19.02% | 29.74% |
| Shareholder Count | 131 | 9,125 | 135 | 9,126 | 11,412 | 109 |
Anlon Healthcare Dividend Screener - Share Yield Analysis
Screen AHCL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Anlon Healthcare Index Membership - Market Screener Classification
Screen AHCL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Anlon Healthcare Market Events Screener - Corporate Actions
Screen AHCL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 2.44% |
Anlon Healthcare Competitors Screener - Peer Comparison
Screen AHCL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 415,061 | 40.31 | 54,729 | 9.71% | 10,980 | 44.32 |
| Divis Laboratories | 175,647 | 70.47 | 9,712 | 18.67% | 2,191 | 60.68 |
| Torrent Pharmaceuticals | 134,139 | 63.66 | 11,539 | 6.99% | 1,911 | 61.70 |
| Cipla | 118,395 | 21.71 | 28,410 | 7.12% | 5,291 | 38.82 |
| Dr Reddys Laboratories | 100,999 | 17.57 | 33,741 | 16.73% | 5,725 | 31.03 |
| Lupin | 99,683 | 23.02 | 22,910 | 13.74% | 3,306 | 63.83 |
| Mankind Pharma | 90,850 | 52.52 | 12,744 | 20.90% | 2,007 | 48.57 |
| Zydus Life Science | 90,048 | 18.16 | 23,511 | 18.55% | 4,615 | 35.88 |
| Aurobindo Pharma | 69,621 | 20.49 | 32,346 | 9.43% | 3,484 | 48.80 |
| Alkem Laboratories | 69,336 | 28.76 | 13,458 | 3.70% | 2,216 | 63.14 |
Anlon Healthcare Company Announcements - News Screener
Screen AHCL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-11 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-11 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-11 | Announcement With Continuation Of Our Earlier Intimation Dated December 02 2025 Regarding The Execution Of Share Purchase Agreement Dated December 2 2025. | View |
| 2026-01-09 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2026-01-09 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2026-01-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-29 | Closure of Trading Window | View |
| 2025-12-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-19 | Announcement As Per Reg. 30 Of SEBI (LODR) Regulation 2015 | View |
| 2025-12-18 | Results-Delay in Financial Results | View |
| 2025-12-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-08 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-12-05 | Board Meeting Outcome for Held On Friday December 05 2025 | View |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | View |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | View |
| 2025-11-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |